Adaptogenics Health Corp. (CSE: ADPT) Eyes Opportunities Beyond Standard Peptides as Policy Opens Pharmacy and Telehealth Channels

Disseminated on behalf of Adaptogenics Health Corp. and may include paid advertising.

• The federal government is working on an interim peptide access policy that would let specialty pharmacies to produce certain peptides while formal rulemaking proceeds.
• Adaptogenics plans to develop delivery technologies to improve the stability, exposure, administration and performance of selected peptides.
• The company has also acquired nutritional research assets developed by Berkwood Research to support a GLP-1 companion initiative.

U.S. Health Secretary Robert F. Kennedy Jr. has made his view plain. Americans, he said, are going to buy peptides anyway, so the government should make sure they come from inspected sources. That push could reshape how peptides reach patients, opening new opportunities for pharmacies, telehealth platforms and companies with something more to offer than standard ingredients. Adaptogenics (CSE: ADPT) is positioning itself for that shift.

Kennedy laid out his case in a Fox News appearance this month, explaining that the administration is working on an interim access policy that would let specialty pharmacies produce certain peptides while formal rulemaking proceeds. The report cited estimates…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to ADPT are available in the company’s newsroom at https://nnw.fm/ADPT

About NetworkNewsWire

NetworkNewsWire (“NNW”) is a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled recognition and brand awareness. NNW is where breaking news, insightful content and actionable information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: https://www.NetworkNewsWire.com/Disclaimer

NetworkNewsWire
Austin, Texas
www.NetworkNewsWire.com
512.354.7000 Office
[email protected]

NetworkNewsWire is powered by IBN

This contant was orignally distributed by InvestorBrandNetwork (IBN). Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is Adaptogenics Health Corp. (CSE: ADPT) Eyes Opportunities Beyond Standard Peptides as Policy Opens Pharmacy and Telehealth Channels.